fda glp-1 compounding enforcement news october 2025 Non-Traditional Channels: The Compounded Market New project announcement: HHS‑OIG is

BPC157 has been hypothesized to interact with cellular signalling pathways and growth factors as well as the workings of the laboratory, although its use in humans is mostly confined to theory

Consult a qualified healthcare professional before making any health-related decision.

PMID: 275111188

These include: Inappropriate dosing or frequency Lack of proper diagnosis and monitoring Non-sterile injection technique increasing infection risk Absence of medical supervision for adverse reactions Financial cost without clinical benefit Patients should report any suspected adverse reactions to B12 injections via the MHRA Yellow Card scheme